A Placebo Controlled, Double-Blind Evaluation of Levamisole in the Reduction of the Frequency, Duration and Severity of Attacks in Children Suffering from Recurrent Upper Respiratory Tract Infections
1979 ◽
Vol 7
(4)
◽
pp. 302-304
◽
Keyword(s):
In a double-blind placebo controlled study of levamisole in the treatment of children with recurrent upper respiratory tract infection (URI) eighty-six patients took part. Medication was given once a week, in a single body-weight adjusted dose. The children treated with levamisole had a statistically significantly reduced incidence of episodes of infection which were less severe, less prolonged and required less antibiotics. No side-effects were reported.
2019 ◽
Vol 102
(6)
◽
pp. 4783-4797
◽
1979 ◽
Vol 6
(2)
◽
pp. 142-147
◽
2018 ◽
Vol 38
(1)
◽
pp. 40-50
◽
1982 ◽
Vol 56
(5)
◽
pp. 434-453
◽
1998 ◽
Vol 7
(6)
◽
pp. 541-545
◽